Sanofi and Arabio push pilgrim vaccination agenda at Umrah forum

By AI, Created 10:19 AM UTC, May 20, 2026, /AGP/ – Sanofi and Arabio used the Umrah and Ziyarah Forum 2026 in Madinah to launch the Himaya initiative and argue for vaccination as a core part of pilgrim preparedness. The effort aims to normalize protection against meningitis, flu and COVID for millions of Umrah travelers as Saudi Arabia scales up pilgrimage capacity under Vision 2030.

Why it matters: - Sanofi and Arabio are trying to make health protection a standard part of the pilgrim journey, not an afterthought. - The push targets mass gatherings where disease prevention affects pilgrims, local health systems and the communities travelers return to. - Saudi Arabia wants to welcome 30 million Umrah performers annually under Vision 2030, raising the stakes for crowd health and disease control.

What happened: - The Umrah and Ziyarah Forum 2026 in Madinah drew more than 29,000 visitors from 165 countries. - Sanofi and Arabio introduced the Himaya initiative at the forum through a public showcase and a dedicated panel on pilgrim health preparedness. - The panel, titled “Health Preparedness and Preventive Measures for Pilgrims and Visitor Services,” brought together health and industry leaders. - The discussion focused on meningococcal meningitis prevention and on aligning health, regulatory and technical entities across the pilgrim journey.

The details: - More than eight million unique Umrah performers were recorded in the first quarter of 2025. - The source describes Umrah as a year-round movement of people from more than 180 countries into the holy sites. - The forum conversation moved toward operational vaccination planning for Umrah performers, not just scientific discussion. - Dr. Abdulla Assiri, Deputy Minister for Population Health at the Ministry of Health, said Hajj and Umrah pilgrims are a priority for the ministry and that the Himaya initiative, in collaboration with the Ministry of Hajj and Umrah, is meant to raise awareness, communicate health requirements and encourage early vaccination. - Baptiste De Clarens, General Manager Vaccines at Sanofi Greater Gulf, said the collaboration with Arabio and Saudi health authorities is meant to define a new standard of care for pilgrims. - Rehan Ahmed, Acting CEO at Arabio, said total coordination across the pilgrim and medical ecosystem is needed to make the meningitis vaccine accessible, understood and accepted. - Himaya means protection in Arabic. - The initiative aims to make vaccination against meningitis, flu and COVID as routine as packing Ihram. - Pilgrims are invited to book meningitis vaccination through the Sehhaty App on iOS and Android at least 10 days before travel. - One appointment provides five years of protection.

Between the lines: - The forum gave healthcare companies a platform inside an event dominated by travel, hospitality and pilgrimage operators. - The message from Sanofi, Arabio and Saudi health officials was that prevention is becoming part of pilgrimage infrastructure, not a separate medical service. - The emphasis on vaccination reflects a broader shift toward managing mass gatherings through advance planning rather than last-minute intervention.

What’s next: - Himaya will continue promoting vaccination for meningitis, flu and COVID as part of pilgrim preparation. - The initiative is positioned to support Saudi Arabia’s wider mass-gathering health agenda and local vaccine manufacturing goals. - Pilgrims can use the Sehhaty App to schedule vaccination before travel, with the campaign urging appointments at least 10 days in advance.

The bottom line: - Sanofi and Arabio are betting that pilgrim health can be normalized through early vaccination, tighter coordination and a public-health message delivered where millions make travel decisions.